Genmab — Juni 2018
-
US
/ROW -
290? Q1 var 264
-
og alle regner med flatlining på 1st line godkendelse?
-
men det er jo i en Combi, der ikke bliver brugt i US
-
og først kommer i EU i August
-
but lets hope for better
-
en ting er at GEN smider alle dara pengene væk - men dara er altså en guldkalv
-
Imponerende den er i plus i dag i så surt et marked. Men godt nok en tynd omsætning.
-
så alle regner med flatlining på Alcyone
-
HAHAHA
-
jep - det tager vi med i estimatet for ROW
-
alcyone bruges ikke i US
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind